Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
CD40 ligand/interferon-γ matured DC immunization with gp100 antigen HLA class I A *0201 restricted peptides in patients with newly diagnosed metastatic melanoma.
Adjuvant dendritic cell (DC)-based vaccine therapy of melanoma patients.
Allogeneic partially HLA-matched dendritic cells (DC) as a vaccine in metastatic renal cell cancer (mRCC): Final analysis of a clinical phase I/II study.
Dendritic/tumor fusion cells as cancer vaccines
[Dendritic cell-based therapeutic vaccination for acute myeloid leukemia]
Cancer therapy and vaccination
Cancer immunotherapy: a paradigm shift for prostate cancer treatment
Velogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization
Successful treatment of advanced ovarian cancer with thermochemotherapy and adjuvant immune therapy
Hyperthermia-enhanced TRAIL- and mapatumumab-induced apoptotic death is mediated through mitochondria in human colon cancer cells
Current status of immunological approaches for the treatment of prostate cancer
Co-culture of apoptotic breast cancer cells with immature dendritic cells: a novel approach for DC-based vaccination in breast cancer
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors
Hyperthermia induces cytoskeletal alterations and mitotic catastrophe in p53-deficient H1299 lung cancer cells
Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease
Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients
Cellular immunotherapy using dendritic cells against multiple myeloma
Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: a potential modality for inducing long-term survival in selected patients
The blockade of immune checkpoints in cancer immunotherapy